Cargando…
Shensong Yangxin Capsule Reduces the Susceptibility of Arrhythmia in db/db Mice via Inhibiting the Inflammatory Response Induced by Endothelium Dysfunction
PURPOSE: The aim of our study was to investigate the mechanism by which the Chinese compound Shensong Yangxin Capsule (SSYX) reduces susceptibility to arrhythmia in db/db mice. METHODS: The db/db mice without drug treatment served as the model group. Other-treated db/db mice were administered SSYX f...
Autores principales: | Zhang, Jiehan, Li, Hongrong, Wang, Dandong, Gu, Jiaojiao, Hou, Yunlong, Wu, Yiling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912345/ https://www.ncbi.nlm.nih.gov/pubmed/36776448 http://dx.doi.org/10.2147/DDDT.S392328 |
Ejemplares similares
-
Effect of the Shensong Yangxin Capsule on Energy Metabolism in Angiotensin II-Induced Cardiac Hypertrophy
por: Liu, Bei-Lei, et al.
Publicado: (2018) -
Shensong Yangxin Protects Against Metabolic Syndrome-Induced Ventricular Arrhythmias by Inhibiting Electrical Remodeling
por: Yang, Hong-Jie, et al.
Publicado: (2020) -
Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure
por: Ma, Jin, et al.
Publicado: (2018) -
Clinical Efficacy and Safety of Shensong Yangxin Capsule-Amiodarone Combination on Heart Failure Complicated by Ventricular Arrhythmia: A Meta-Analysis of Randomized Controlled Trials
por: Cao, Xinfu, et al.
Publicado: (2021) -
Effect of Shensong Yangxin on the Progression of Paroxysmal Atrial Fibrillation is Correlated with Regulation of Autonomic Nerve Activity
por: Zhao, Hong-Yi, et al.
Publicado: (2017)